CN102552517A - Gynecological sugar-free gynaecopathia treating particle and preparation method thereof - Google Patents
Gynecological sugar-free gynaecopathia treating particle and preparation method thereof Download PDFInfo
- Publication number
- CN102552517A CN102552517A CN201110448948XA CN201110448948A CN102552517A CN 102552517 A CN102552517 A CN 102552517A CN 201110448948X A CN201110448948X A CN 201110448948XA CN 201110448948 A CN201110448948 A CN 201110448948A CN 102552517 A CN102552517 A CN 102552517A
- Authority
- CN
- China
- Prior art keywords
- parts
- gynecological
- fukang
- hours
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002245 particle Substances 0.000 title claims abstract description 7
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000000341 volatile oil Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000003085 diluting agent Substances 0.000 claims abstract description 7
- 239000000080 wetting agent Substances 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 32
- 108010052008 colla corii asini Proteins 0.000 claims description 26
- 239000002671 adjuvant Substances 0.000 claims description 20
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 15
- 229920001353 Dextrin Polymers 0.000 claims description 13
- 239000004375 Dextrin Substances 0.000 claims description 13
- 235000019425 dextrin Nutrition 0.000 claims description 13
- 229920002472 Starch Polymers 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 108010011485 Aspartame Proteins 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 239000000605 aspartame Substances 0.000 claims description 6
- 235000010357 aspartame Nutrition 0.000 claims description 6
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 6
- 229960003438 aspartame Drugs 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 235000010356 sorbitol Nutrition 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 229940013618 stevioside Drugs 0.000 claims description 4
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 4
- 235000019202 steviosides Nutrition 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 229940109275 cyclamate Drugs 0.000 claims description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 4
- 108010010803 Gelatin Proteins 0.000 abstract 3
- 229920000159 gelatin Polymers 0.000 abstract 3
- 239000008273 gelatin Substances 0.000 abstract 3
- 235000019322 gelatine Nutrition 0.000 abstract 3
- 235000011852 gelatine desserts Nutrition 0.000 abstract 3
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 235000010894 Artemisia argyi Nutrition 0.000 abstract 2
- 241000212322 Levisticum officinale Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 241001106477 Paeoniaceae Species 0.000 abstract 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- 244000030166 artemisia Species 0.000 abstract 2
- 239000001645 levisticum officinale Substances 0.000 abstract 2
- 229960004793 sucrose Drugs 0.000 abstract 2
- 239000007767 bonding agent Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 19
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 206010000210 abortion Diseases 0.000 description 6
- 231100000176 abortion Toxicity 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 206010046788 Uterine haemorrhage Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001605 fetal effect Effects 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000004680 Rectal Fistula Diseases 0.000 description 3
- 206010002156 anal fistula Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000003785 decidua Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- ZJTLZYDQJHKRMQ-UHFFFAOYSA-N menadiol Chemical compound C1=CC=CC2=C(O)C(C)=CC(O)=C21 ZJTLZYDQJHKRMQ-UHFFFAOYSA-N 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal sugar-free gynaecopathia treating particle for treating gynaecopathia and a preparation method thereof. The particle is prepared from the following raw and auxiliary materials in parts by weight: 115 parts of prepared rehmannia root, 46 parts of szechuan lovage rhizome, 93 parts of white paeony root, 46 parts of Chinese mugwort leaf, 69 parts of Chinese angelica, 46 parts of liquoric root, 69 parts of donkey-hide gelatin, and non-cane-sugar auxiliary materials consisting of 100-800 parts of a diluent, 0-100 parts of a wetting agent, 0-50 parts of a bonding agent and 0-10 parts of a flavoring agent. The preparation method comprises the following steps of: extracting volatile oil from Chinese angelica, Chinese mugwort leaf and szechuan lovage rhizome, adding water into decoction dregs, white paeony root, prepared rehmannia root and liquoric root for decocting twice for 3 hours in a first time and 2 hours in a second time, combining decoctions, standing for 18-24 hours, and filtering to obtain an extract; and smashing the donkey-hide gelatin, adding donkey-hide gelatin powder and non-cane-sugar auxiliary material powder into the extract, preparing into particles, drying and spraying volatile oil. The particle is a sugar-free preparation, and is suitable for people suffering from diabetes and other people with no sugar requirements; and the using amount of the auxiliary materials is lowered remarkably.
Description
Technical field
The invention belongs to the technical field of pharmaceuticals of treatment gynaecopathia, be specifically related to a kind of Chinese medicine Sugarless type FUKANG nourishing granules of treating gynaecopathia and preparation method thereof.
Background technology
Present dysmenorrhea; In the early stage pregnant drug induced abortion of being pregnent, artificial abortion, cuing open the palace, to produce the vaginal hemorrhage that causes be commonly encountered diseases, the frequently-occurring disease of young women, serious modern female, the physical and mental health that is endangering vast young women of perplexing; Doctor trained in Western medicine is many at present with treatment dysmenorrheas such as ibuprofen, treatment vaginal hemorrhage methylnaphthohydroquinone added with antibiotic commonly used; But all side effect is big, and therapeutic effect is unequal to obviously, unsuitable conventional the use.Motherland's medical science thinks that the women is this with blood; Women all one's life through, pregnant, produce, the physiological characteristics of breast is all relevant with blood; All are processes of blood trouble hematozemia; Women's warp, band, bitterly, to leak all diseases also relevant with blood, the precious prescription of FUKANG effectively embodied invigorates blood circulation and enriches blood, nourishing the liver with the kidney invigorating, treat and nurse one's health the characteristics that combine.The FUKANG treasured can tonifying blood and regulating menstruation, again can arresting bleeding and miscarriage prevention, can be widely used in severe loss of blood, shallow complexion, menoxenia, cold and pain in the lower abdomen, vaginal bleeding during pregnancy fetal movement, anal fistula hematochezia in clinical.
The FUKANG treasured comes from the Han dynasty and cures " golden plaque outline " rhizome of chuanxiong of holy Zhang Zhongjing and return Ass-hide Glue and Argyi Leaf Decoction; But existing 'Fukangbao ' all contains sugar; Very big clinical use limitation is arranged, especially for diabetes patient, obese patient and the Ms that likes to be beautiful who dislikes absorbing too much sugar significant limitation is arranged.
In addition, existing 'Fukangbao ' all contains sugar and sugar content is very high, needs to use a large amount of adjuvants, the resource of waste adjuvant.
Summary of the invention
The objective of the invention is in order to solve the problem of above-mentioned existence, and provide a kind of for any crowd's thing clinical use circumscribed Sugarless type FUKANG nourishing granules and method for preparing.
In order to realize this purpose; Gynecological provided by the invention Sugarless type FUKANG nourishing granules; The granule that it is processed by the supplementary material of following weight proportioning: 115 parts of Radix Rehmanniae Preparata, 46 parts of Rhizoma Chuanxiongs, 93 parts of the Radix Paeoniae Albas, 46 parts of Folium Artemisiae Argyis, 69 parts of Radix Angelicae Sinensis, 46 parts in Radix Glycyrrhizae, 69 parts in Colla Corii Asini, and by 100~800 parts of diluent, 0~100 part of wetting agent, 0~50 part of adhesive, 0~10 part of non-sucrose adjuvant of forming of correctives; Said diluent is a kind of adjuvant or the compositions of more than one adjuvants in dextrin, lactose, soluble starch, mannitol, the sorbitol; Said wetting agent is an ethanol; Said adhesive is a kind of adjuvant or the compositions of more than one adjuvants in starch slurry, methylcellulose, carboxymethyl cellulose, the hydroxypropyl cellulose; Said correctives is a kind of adjuvant or the compositions of more than one adjuvants in cyclamate, stevioside, aspartame, xylitol, Sorbitol, the acesulfame potassium.
Preferably, diluent described in the technique scheme is that dextrin, lactose, soluble starch are the compositions of adjuvant; Said wetting agent is that concentration is 75%~95% ethanol; Said adhesive is the compositions of starch slurry and carboxymethyl cellulose; Said correctives is the compositions of stevioside and aspartame.
The method for preparing of gynecological provided by the invention Sugarless type FUKANG nourishing granules may further comprise the steps:
1., Radix Angelicae Sinensis, Folium Artemisiae Argyi, Rhizoma Chuanxiong extract volatile oil;
2., will extract medicinal residues and the Radix Paeoniae Alba, Radix Rehmanniae Preparata, Radix Glycyrrhizae decocte with water secondary behind the volatile oil, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 18~24 hours, and filtered, filtrating is condensed into the extractum that relative density is 1.20~1.40 (30 ℃~60 ℃);
3., Colla Corii Asini is pulverized, in extractum, add Colla Corii Asini powder and non-sucrose adjuvant fine powder after pulverizing, process granule, drying sprays into volatile oil;
4., the granule mixing that makes, be distributed into bag.
Preferably, the step in the technique scheme 2. in, the relative density of concentrated extract is 1.25~1.35 (30 ℃~60 ℃).
Preferably, the step in the technique scheme 3. in, drying is under temperature is 60 ℃~90 ℃ condition, to carry out;
Preferably, the step in the technique scheme 3. in, contain moisture less than 6.0% behind the particle drying of processing.
Preferably, the step in the technique scheme 4. in, the net content of packing granule is 3~9 gram/bags or 3~9 gram/bottles.
Gynecological of the present invention Sugarless type FUKANG nourishing granules according to its component analysis, belongs to Chinese patent medicine, natural drug; Prescription reasonable recipe, science, no incompatibility, avirulence medical material, the high strong medical material of no flavour of a drug in the prescription; No eighteen imcompatible pairs, nineteen medicaments of mutual restraint, safe, prescription will invigorate blood circulation with enrich blood, nourishing the liver combines with conditioning with the kidney invigorating, treatment; Can tonifying blood and regulating menstruation, again can arresting bleeding and miscarriage prevention, and applicable to the diabetes patient and the vast Ms of liking to be beautiful who dislikes taking too many sugar; Significantly reduce supplementary product consumption, economize on resources.
Can be widely used in severe loss of blood, shallow complexion, menoxenia in clinical; Cold and pain in the lower abdomen, vaginal bleeding during pregnancy fetal movement, anal fistula hematochezia; Its pharmacological action: the Han dynasty is cured " golden plaque outline " rhizome of chuanxiong of holy Zhang Zhongjing and is returned Ass-hide Glue and Argyi Leaf Decoction, and rhizome of chuanxiong returns Ass-hide Glue and Argyi Leaf Decoction to add Colla Corii Asini, Folium Artemisiae Argyi, Radix Glycyrrhizae by SIWU TANG to form Colla Corii Asini nourishing blood hemostasis in the side; The Folium Artemisiae Argyi warming the meridian for stopping bleeding, it is antiabortive that the two share regulating menstruation, for controlling the key medicine that collapses leak-stopping; Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Alba nourshing blood and promoting blood circulation, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, all medicines share, and get final product nourishing blood and hemoslasis, and are again can regulating menstruation antiabortive.The modern pharmacology pharmacodynamic study shows that medicine of the present invention can obviously reduce metrorrhagia amount and persistent period behind the pregnant drug induced abortion of being pregnent of early metaphase, can promote decidua to strip off discharge, and can improve the menstruation compound tides behind the drug induced abortion.Can improve behind the cesarean section puerpera's body void symptom of losing blood, reduce the vaginal hemorrhage amount, improve hemoglobin content and RBC level, help improving puerpera's body constitution, enhancing human body immunity power.
The medicine that will make according to prescription of the present invention and method for preparing is used for severe loss of blood, shallow complexion, and menoxenia, cold and pain in the lower abdomen, the vaginal bleeding during pregnancy fetal movement, the clinical trial of anal fistula hematochezia disease, therapeutic effect is good:
1, the medicine that makes according to prescription of the present invention and method for preparing is used to treat the clinical trial of dysmenorrhea:
Drug therapy primary dysmenorrhea 45 examples that Suzhou City hospital uses prescription of the present invention and method for preparing to make, and compare with 41 examples of previous employing ibuprofen treatment: cured substance rate 66.7% of the present invention as a result, total effective rate 95.6%; Ibuprofen cure rate 48.87%, total effective rate 75.6%; Both differences have significance (P<0.01), and it is better to show that the present invention treats the dysmenorrhea curative effect.
2, the medicine that makes according to prescription of the present invention and method for preparing is used to treat the clinical trial of colporrhagia due to abortion:
Henan Province hospital adopts Drug therapy oral drugs colporrhagia due to abortion 60 examples of the present invention, and clinical observation shows: the bleeding time obviously shortens, treatment recovery from illness 39 examples; Produce effects 11 examples, effective 5 examples, invalid 5 examples; Cure-remarkable-effectiveness rate is 83.3%, and total effective rate is 91.7%, and therapeutic effect is good.
Zhejiang Province healthcare hospital for women & children uses hemorrhage 40 examples of Drug therapy drug flow postpartum vaginal of invention, and clinical observation shows: Drug therapy drug flow postpartum vaginal of the present invention is hemorrhage, and the overall bleeding time obviously shortens; Treatment recovery from illness 18 examples, produce effects 15 examples, effective 5 examples; Invalid 2 examples; Cure-remarkable-effectiveness rate is 87.5%, and total effective rate is 95%, and therapeutic effect is good.
3, the medicine that makes according to prescription of the present invention and method for preparing is used for the clinical trial of vaginal bleeding during pregnancy fetal movement:
Chongqing City hospital has chosen 10 routine patients' vaginal bleeding during pregnancy fetal movement patient, and the patient is at pregnancy duration, and the soreness of waist is suffered from abdominal pain, or sagging distention in the smaller abdomen; Or, adopt clinical observation after the Drug therapy of the present invention with a small amount of colporrhagia person, and can not only stop blooding, alleviate clinical symptoms such as stomachache, the soreness of waist; Wherein treat recovery from illness 5 examples, produce effects 2 examples, effective 2 examples, invalid 1 example; Cure-remarkable-effectiveness rate is 70%, and total effective rate is 90%, and therapeutic effect is good.
The specific embodiment
Below in conjunction with embodiment the present invention is done further detailed description, be convenient to be well understood to the present invention, but they do not constitute qualification to the present invention.
Embodiment one:
Gynecological's Sugarless type FUKANG nourishing granules is prepared into by Radix Rehmanniae Preparata 115g, Rhizoma Chuanxiong 46g, Radix Paeoniae Alba 93g, Folium Artemisiae Argyi 46g, Radix Angelicae Sinensis 69g, Radix Glycyrrhizae 46g, Colla Corii Asini 69g, dextrin 200 grams, lactose 160 grams, dextrin 200 grams, lactose 160 grams, steviosin 0.3 gram.
The method for preparing that it is concrete: Radix Angelicae Sinensis 69g, Folium Artemisiae Argyi 93g, Rhizoma Chuanxiong 46g extracting in water volatile oil; Medicinal residues and Radix Paeoniae Alba 93g, Radix Rehmanniae Preparata 115g, Radix Glycyrrhizae 46g decocte with water twice, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 18 hours, and filtered, it is 1.20 extractum that filtrating is condensed in the time of 60 ℃ relative density.Colla Corii Asini 69g pulverizes, and adds the Colla Corii Asini powder pulverized and dextrin 200 grams, lactose 160 grams, steviosin 0.3 gram in the extractum, processes granule, and drying is put coldly, sprays into the volatile oil of said extracted, mixing, and being distributed into net content is 3 gram/bags, promptly gets.
Embodiment two:
Gynecological's Sugarless type FUKANG nourishing granules is to be prepared into by Radix Rehmanniae Preparata 115g, Rhizoma Chuanxiong 46g, Radix Paeoniae Alba 93g, Folium Artemisiae Argyi 46g, Radix Angelicae Sinensis 69g, Radix Glycyrrhizae 46g, Colla Corii Asini 69g, dextrin 200 grams, mannitol 200 grams, steviosin 0.3 gram.
The method for preparing that it is concrete: Radix Angelicae Sinensis 69g, Folium Artemisiae Argyi 93g, Rhizoma Chuanxiong 46g extracting in water volatile oil; Medicinal residues and Radix Paeoniae Alba 93g, Radix Rehmanniae Preparata 115g, Radix Glycyrrhizae 46g decocte with water twice, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 21 hours, and filtered, it is 1.35 extractum that filtrating is condensed in the time of 45 ℃ relative density.Colla Corii Asini 69g pulverizes, and adds the Colla Corii Asini powder pulverized and dextrin 200 grams, mannitol 200 grams, steviosin 0.3 gram in the extractum, processes granule, and drying is put coldly, sprays into the volatile oil of said extracted, mixing, and being distributed into net content is 6 gram/bags, promptly gets.
Embodiment three:
Gynecological's Sugarless type FUKANG nourishing granules is to be prepared into by Radix Rehmanniae Preparata 115g, Rhizoma Chuanxiong 46g, Radix Paeoniae Alba 93g, Folium Artemisiae Argyi 46g, Radix Angelicae Sinensis 69g, Radix Glycyrrhizae 46g, Colla Corii Asini 69g, dextrin 600 grams, aspartame 0.3 gram.
The method for preparing that it is concrete: Radix Angelicae Sinensis 69g, Folium Artemisiae Argyi 93g, Rhizoma Chuanxiong 46g extracting in water volatile oil; Medicinal residues and Radix Paeoniae Alba 93g, Radix Rehmanniae Preparata 115g, Radix Glycyrrhizae 46g decocte with water twice, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 18~24 hours, and filtered, it is 1.40 extractum that filtrating is condensed in the time of 60 ℃ relative density.Colla Corii Asini 69g pulverizes, and adds the Colla Corii Asini powder pulverized and dextrin 600 grams, aspartame 0.3 gram in the extractum, processes granule, and drying is put coldly, sprays into the volatile oil of said extracted, mixing, and being distributed into net content is 9 gram/bags, promptly gets.
Embodiment four:
Gynecological's Sugarless type FUKANG nourishing granules is to be prepared into by Radix Rehmanniae Preparata 115g, Rhizoma Chuanxiong 46g, Radix Paeoniae Alba 93g, Folium Artemisiae Argyi 46g, Radix Angelicae Sinensis 69g, Radix Glycyrrhizae 46g, Colla Corii Asini 69g, lactose 200 grams, mannitol 200 grams, saccharin sodium 0.3 gram.
The method for preparing that it is concrete: Radix Angelicae Sinensis 69g, Folium Artemisiae Argyi 93g, Rhizoma Chuanxiong 46g extracting in water volatile oil; Medicinal residues and Radix Paeoniae Alba 93g, Radix Rehmanniae Preparata 115g, Radix Glycyrrhizae 46g decocte with water twice, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 20 hours, and filtered, it is 1.25 extractum that filtrating is condensed into 40 ℃ of relative densities.Colla Corii Asini 69g pulverizes, and adds the Colla Corii Asini powder pulverized and lactose 200 grams, mannitol 200 grams, saccharin sodium 0.3 gram in the extractum, processes granule, and drying is put coldly, sprays into the volatile oil of said extracted, mixing, and being distributed into net content is 8 gram/bags, promptly gets.
Embodiment five:
Gynecological's Sugarless type FUKANG nourishing granules is to be prepared into by Radix Rehmanniae Preparata 115g, Rhizoma Chuanxiong 46g, Radix Paeoniae Alba 93g, Folium Artemisiae Argyi 46g, Radix Angelicae Sinensis 69g, Radix Glycyrrhizae 46g, Colla Corii Asini 69g, dextrin 200 grams, soluble starch 300 grams, mannitol 200 grams, xylitol 3 grams.
The method for preparing that it is concrete: Radix Angelicae Sinensis 69g, Folium Artemisiae Argyi 93g, Rhizoma Chuanxiong 46g extracting in water volatile oil; Medicinal residues and Radix Paeoniae Alba 93g, Radix Rehmanniae Preparata 115g, Radix Glycyrrhizae 46g decocte with water twice, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 18 hours, and filtered, it is 1.25 extractum that filtrating is condensed in the time of 50 ℃ relative density.Colla Corii Asini 69g pulverizes, and adds the Colla Corii Asini powder pulverized and dextrin 200 grams, soluble starch 300 grams, mannitol 200 grams, xylitol 3 grams in the extractum, processes granule, and drying is put coldly, sprays into the volatile oil of said extracted, mixing, and being distributed into net content is 9 gram/bags, promptly gets.
Embodiment six:
Gynecological's Sugarless type FUKANG nourishing granules is to be prepared into by Radix Rehmanniae Preparata 115g, Rhizoma Chuanxiong 46g, Radix Paeoniae Alba 93g, Folium Artemisiae Argyi 46g, Radix Angelicae Sinensis 69g, Radix Glycyrrhizae 46g, Colla Corii Asini 69g, soluble starch 200 grams, mannitol 200 grams, lactose 160 grams, Sorbitol 1.0 grams.
The method for preparing that it is concrete: Radix Angelicae Sinensis 69g, Folium Artemisiae Argyi 93g, Rhizoma Chuanxiong 46g extracting in water volatile oil; Medicinal residues and Radix Paeoniae Alba 93g, Radix Rehmanniae Preparata 115g, Radix Glycyrrhizae 46g decocte with water twice, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 19 hours, and filtered, it is 1.30 extractum that filtrating is condensed in the time of 55 ℃ relative density.Colla Corii Asini 69g pulverizes, and Colla Corii Asini powder that adding is pulverized in the extractum and soluble starch 200 grams, mannitol 200 grams, lactose 160 grams, Sorbitol 1.0 restrain, and process granule; Drying is put coldly, sprays into the volatile oil of said extracted; Mixing, being distributed into net content is 6 gram/bags, promptly gets.
The content of not doing in this description to describe in detail belongs to this area professional and technical personnel's known prior art.
Claims (7)
1. gynecological's Sugarless type FUKANG nourishing granules; It is characterized in that the granule that it is processed by the supplementary material of following weight proportioning: 115 parts of Radix Rehmanniae Preparata, 46 parts of Rhizoma Chuanxiongs, 93 parts of the Radix Paeoniae Albas, 46 parts of Folium Artemisiae Argyis, 69 parts of Radix Angelicae Sinensis, 46 parts in Radix Glycyrrhizae, 69 parts in Colla Corii Asini, and by 100~800 parts of diluent, 0~100 part of wetting agent, 0~50 part of adhesive, 0~10 part of non-sucrose adjuvant of forming of correctives; Said diluent is a kind of adjuvant or the compositions of more than one adjuvants in dextrin, lactose, soluble starch, mannitol, the sorbitol; Said wetting agent is an ethanol; Said adhesive is a kind of adjuvant or the compositions of more than one adjuvants in starch slurry, methylcellulose, carboxymethyl cellulose, the hydroxypropyl cellulose; Said correctives is a kind of adjuvant or the compositions of more than one adjuvants in cyclamate, stevioside, aspartame, xylitol, Sorbitol, the acesulfame potassium.
2. gynecological according to claim 1 Sugarless type FUKANG nourishing granules is characterized in that: said diluent is that dextrin, lactose, soluble starch are the compositions of adjuvant; Said wetting agent is that concentration is 75%~95% ethanol; Said adhesive is the compositions of starch slurry and carboxymethyl cellulose; Said correctives is the compositions of stevioside and aspartame.
3. the method for preparing of claim 1 or 2 said gynecological Sugarless type FUKANG nourishing granules is characterized in that may further comprise the steps:
1., Radix Angelicae Sinensis, Folium Artemisiae Argyi, Rhizoma Chuanxiong extract volatile oil;
2., will extract medicinal residues and the Radix Paeoniae Alba, Radix Rehmanniae Preparata, Radix Glycyrrhizae decocte with water secondary behind the volatile oil, 3 hours for the first time, 2 hours for the second time; Collecting decoction; Left standstill 18~24 hours, and filtered, filtrating is condensed into the extractum that relative density is 1.20~1.40 (30 ℃~60 ℃);
3., Colla Corii Asini is pulverized, in extractum, add Colla Corii Asini powder and non-sucrose adjuvant fine powder after pulverizing, process granule, drying sprays into volatile oil;
4., the granule mixing that makes, be distributed into bag.
4. according to the method for preparing of the said gynecological of claim 3 Sugarless type FUKANG nourishing granules, it is characterized in that, step 2. in, the relative density of concentrated extract is 1.25~1.35 (30 ℃~60 ℃).
5. according to the method for preparing of the said gynecological of claim 3 Sugarless type FUKANG nourishing granules, it is characterized in that, step 3. in, drying is under temperature is 60 ℃~90 ℃ condition, to carry out.
6. according to the method for preparing of the said gynecological of claim 3 Sugarless type FUKANG nourishing granules, it is characterized in that, step 3. in, contain moisture less than 6.0% behind the particle drying of processing.
7. according to the method for preparing of the said gynecological of claim 3 Sugarless type FUKANG nourishing granules, it is characterized in that, step 4. in, the net content of packing granule is 3~9 gram/bags or 3~9 gram/bottles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110448948XA CN102552517A (en) | 2011-12-28 | 2011-12-28 | Gynecological sugar-free gynaecopathia treating particle and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110448948XA CN102552517A (en) | 2011-12-28 | 2011-12-28 | Gynecological sugar-free gynaecopathia treating particle and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102552517A true CN102552517A (en) | 2012-07-11 |
Family
ID=46399972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110448948XA Pending CN102552517A (en) | 2011-12-28 | 2011-12-28 | Gynecological sugar-free gynaecopathia treating particle and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552517A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103169783A (en) * | 2013-03-25 | 2013-06-26 | 薛洪喜 | Medicine for treating anovulatory dysfunctional uterine bleeding |
CN103638129A (en) * | 2013-11-26 | 2014-03-19 | 青岛安信医疗器械有限公司 | Traditional Chinese medicine liquid for treating abdominal pain during pregnancy |
CN104997922A (en) * | 2015-08-05 | 2015-10-28 | 南京中医药大学 | Refined traditional Chinese medicine composition extract with hemostasis and miscarriage prevention effect and application thereof |
CN105079254A (en) * | 2015-09-15 | 2015-11-25 | 宜都市妇幼保健院 | Postpartum healthcare fumigation medicine as well as preparation method and application thereof |
CN108175802A (en) * | 2018-01-30 | 2018-06-19 | 重庆芸峰药业有限公司 | A kind of FUKANGBAO KOUFUYE and preparation method thereof |
CN108498631A (en) * | 2018-06-23 | 2018-09-07 | 贵州威门药业股份有限公司 | Sugarless type danggui tiaojing granule and preparation method thereof |
CN116098962A (en) * | 2022-12-16 | 2023-05-12 | 无锡济煜山禾药业股份有限公司 | Preparation method of life-prolonging and body-building particles |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020035076A (en) * | 2002-04-18 | 2002-05-09 | 문정기 | Health pad for men and women |
CN1368201A (en) * | 2001-02-01 | 2002-09-11 | 杨孟君 | Nano medicine 'Fukangbao' and its preparing process |
CN1748745A (en) * | 2005-06-10 | 2006-03-22 | 湖南协力药业有限公司 | Chinese medicine granular powder for tonifying blood and regulating menstruation, arresting bleeding and miscarriage prevention and its preparing method |
CN1765392A (en) * | 2005-09-02 | 2006-05-03 | 北京润德康医药技术有限公司 | Chinese compound formulation for nourishing blood, regulating menstruation, stopping bleeding to prevent abortion and preparation method thereof |
WO2008119131A1 (en) * | 2007-04-02 | 2008-10-09 | Medcina Group Pty Ltd | Herbal compositions and methods for treating female infertility |
-
2011
- 2011-12-28 CN CN201110448948XA patent/CN102552517A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1368201A (en) * | 2001-02-01 | 2002-09-11 | 杨孟君 | Nano medicine 'Fukangbao' and its preparing process |
KR20020035076A (en) * | 2002-04-18 | 2002-05-09 | 문정기 | Health pad for men and women |
CN1748745A (en) * | 2005-06-10 | 2006-03-22 | 湖南协力药业有限公司 | Chinese medicine granular powder for tonifying blood and regulating menstruation, arresting bleeding and miscarriage prevention and its preparing method |
CN1765392A (en) * | 2005-09-02 | 2006-05-03 | 北京润德康医药技术有限公司 | Chinese compound formulation for nourishing blood, regulating menstruation, stopping bleeding to prevent abortion and preparation method thereof |
WO2008119131A1 (en) * | 2007-04-02 | 2008-10-09 | Medcina Group Pty Ltd | Herbal compositions and methods for treating female infertility |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103169783A (en) * | 2013-03-25 | 2013-06-26 | 薛洪喜 | Medicine for treating anovulatory dysfunctional uterine bleeding |
CN103638129A (en) * | 2013-11-26 | 2014-03-19 | 青岛安信医疗器械有限公司 | Traditional Chinese medicine liquid for treating abdominal pain during pregnancy |
CN104997922A (en) * | 2015-08-05 | 2015-10-28 | 南京中医药大学 | Refined traditional Chinese medicine composition extract with hemostasis and miscarriage prevention effect and application thereof |
CN104997922B (en) * | 2015-08-05 | 2017-11-21 | 南京中医药大学 | The refined extract of Chinese medicine composition with arresting bleeding and miscarriage prevention effect and its application |
CN105079254A (en) * | 2015-09-15 | 2015-11-25 | 宜都市妇幼保健院 | Postpartum healthcare fumigation medicine as well as preparation method and application thereof |
CN105079254B (en) * | 2015-09-15 | 2018-09-11 | 宜都市妇幼保健院 | A kind of postpartum health care fumigates medicine and its preparation method and application |
CN108175802A (en) * | 2018-01-30 | 2018-06-19 | 重庆芸峰药业有限公司 | A kind of FUKANGBAO KOUFUYE and preparation method thereof |
CN108498631A (en) * | 2018-06-23 | 2018-09-07 | 贵州威门药业股份有限公司 | Sugarless type danggui tiaojing granule and preparation method thereof |
CN108498631B (en) * | 2018-06-23 | 2021-06-08 | 贵州威门药业股份有限公司 | Sugar-free angelica sinensis menstruation regulating granules and preparation method thereof |
CN116098962A (en) * | 2022-12-16 | 2023-05-12 | 无锡济煜山禾药业股份有限公司 | Preparation method of life-prolonging and body-building particles |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102342992B (en) | Chinese medicinal composition for treating insomnia and preparation method of preparation thereof | |
CN102552517A (en) | Gynecological sugar-free gynaecopathia treating particle and preparation method thereof | |
CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
CN101757591B (en) | Traditional Chinese medicine composition for treating chronic colitis and protitis | |
CN102836409A (en) | Traditional Chinese medicine for treating postpartum lochiorrhea and preparation method | |
CN104524335A (en) | Pill for conditioning female endocrine disorders and preparation method of pill | |
CN102205064B (en) | Traditional Chinese medicine (TCM) for treating threatened abortion | |
CN102805830A (en) | Traditional Chinese medicine composite for treating acne | |
CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
CN102293923B (en) | Application of Tibetan medicinal composition to preparation of medicament for preventing and treating osteoporosis | |
CN102961468A (en) | Pharmaceutical composition for treating hemorrhoids and preparation method thereof | |
CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
CN104288581A (en) | Traditional Chinese medicine for treating threatened abortion | |
CN114886986A (en) | A Chinese medicinal composition for treating menoxenia, amenorrhea and infertility | |
CN105983020A (en) | Pharmaceutical composition for treating inflammatory external hemorrhoids and application of pharmaceutical composition | |
CN104587122A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
CN104606427A (en) | Schefflera arboricola-contained traditional Chinese medicinal composition | |
CN103800742A (en) | Acne removing composition prepared from medicine-food homologous medicinal materials fully | |
CN104623223A (en) | Traditional Chinese medicine composition for treatment of allergic rhinitis | |
CN105194278A (en) | Drug for treatment of irregular menstruation and preparation method thereof | |
CN105232950A (en) | Medicament for treating menstrual disorder and preparation method thereof | |
CN105770381A (en) | Preparation taken by patients suffering from gastric ulcers and production method of preparation | |
CN105362617A (en) | Medicine for treating chronic urinary retention and preparation method of medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120711 |